Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia [4]

Additional Metadata
Persistent URL	doi.org/10.1038/sj.leu.2404537, hdl.handle.net/1765/36311
Journal	Leukemia
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Yoshimi, A., Mohamed, M., Bierings, M., Urban, C., Korthof, E., Zecca, M., Sykora, K.-W., Duffner, U., Trebo, M., Matthes-Martin, S., Sedlacek, P., Klingebiel, T., Lang, P., Führer, M., Claviez, A., Wössmann, W., Pession, A., Arvidson, J., O'Marcaigh, A., … Niemeyer, C. (2007). Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia [4]. Leukemia, 21(3), 556–560.https://doi.org/10.1038/sj.leu.2404537

Publication